In leukemia, the BCR-ABL1 fusion gene is a known driver oncogene in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.